Mietani et al. demonstrated that postoperative elevated NSE in cancer surgery discriminated, with significantly high accuracy, between patients with and without clinically diagnosed POD (AUC of 0.87 [95% CI 0.79–0.95], p < 0.0001) [27]. The gene discussed is ENO2; the disease is cancer.